Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEN0101 + Pembrolizumab in Advanced Melanoma
NCT03818893Phase 2Unknown
- Sponsor
- The University of Osaka
- Start
- Mar 2019
- Primary completion
- Dec 2021
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
A Phase 2 trial of GEN0101 in melanoma, sponsored by The University of Osaka. Status: unknown.
02
Drugs
GEN0101
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT03818893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03818893.